Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 02 crawled time : 13:20 save search
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: -1.0%
H: 10.61%
C: 9.6%
Coherus and Junshi Biosciences Receive Complete Response Letter from U.S. FDA for Toripalimab BLA
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
CHRS | $2.18 0.46% 57
|
Health Technology
|
| O: -6.26%
H: 8.64%
C: 8.64%
fda response
Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
VAXX | $0.2 -25.82% -34.8% 2M
|
|
| O: -6.84%
H: 5.72%
C: 5.72%
ub-311 treatment fda designation disease alzheimer’s fast track designation alzheimer's
Sorrento Announces Full Enrollment of Phase I Study of Intranasal STI-9199 (COVISHIELD™ IN), a Potent Neutralization Antibody Against Omicron BA.2 and All Variants of Concern
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: 0.0%
H: 8.61%
C: 7.28%
sti-9199 antibody enroll
Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
BVS 4 | $4.31 0.47% 0.0% 6
|
|
| O: 0.83%
H: 0.16%
C: -9.32%
durolane osteoarthritis contract
VBI Vaccines Announces European Commission Marketing Authorisation for PreHevbri™, a 3-Antigen Adult Hepatitis B Vaccine
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
VBIV | $0.6085 0.91% -2.03% 110K
|
Health Technology
|
| O: 0.0%
H: 7.2%
C: 7.2%
hepatitis vaccine
SuperCom Launches Croatia's first National Electronic Monitoring Project
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
SPCB | News 4 d | $0.24 -17.16% -20.71% 8.7M
|
Electronic Technology
|
| O: 0.0%
H: 3.97%
C: 1.61%
Lawful Interception Market Size to Reach USD 22.64 Billion by 2030 at a CAGR of 23.7% | Valuates Reports
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
CSCO | News | $48.32 0.37% 0.35% 49K
|
Technology Services
|
| O: -1.71%
H: 0.0%
C: 0.0%
market
At 39.5% Global CAGR of Metaverse Market Size Worth $400.5 Billion by 2028: Zion Market Research
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
NEXCF | $0.0957 -0.52% -5.74% 450K
|
Technology Services
|
| O: 1.63%
H: 0.0%
C: -7.95%
TCTZF | News | $42.5912 5.69% 2.11% 40K
|
Technology Services
|
| O: 2.32%
H: 0.0%
C: -1.75%
TCEHY | News | $42.48 3.56% 0.04% 4.1M
|
Information
|
| O: -1.1%
H: 1.98%
C: 1.48%
NVDA | News | $824.23 3.65% 4.25% 41M
|
Electronic Technology
|
| O: -0.04%
H: 5.57%
C: 5.35%
NTES | $93.07 -1.91% -1.94% 1.6M
|
Technology Services
|
| O: -1.38%
H: 3.46%
C: 0.3%
MSFT | News 4 | $407.57 1.65% 1.54% 11M
|
Technology Services
|
| O: -3.65%
H: 0.0%
C: 0.0%
research metaverse market
NantHealth to Report 2022 First-Quarter Financial Results and Host Conference Call on Thursday, May 5
Published: 2022-05-02 (Crawled : 13:20) - nanthealth.com
NH | $1.35 -46.64% -1.48% 0
|
Technology Services
|
| O: 2.21%
H: 2.78%
C: 0.03%
conference report results
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
NDRA | $0.2544 1.68% -0.89% 37K
|
Health Technology
|
| O: -1.7%
H: 9.41%
C: 6.0%
report results
LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
LNSR | $3.18 -2.15% 0.31% 14K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -2.46%
report results
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
VERU | $1.275 0.39% 0.0% 2.6M
|
Health Technology
|
| O: 8.28%
H: 2.44%
C: -19.07%
covid-19 fda sabizabulin granted authorization positive phase 3 emergency use authorization
Tarsus Announces Positive Topline Data from Saturn-2 Phase 3, the Second Pivotal Trial of TP-03 for the Treatment of Demodex Blepharitis, and Expects to File a New Drug Application This Year
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
TARS | $33.71 4.4% 4.27% 230K
|
Health Technology
|
| O: -7.69%
H: 0.47%
C: -17.01%
tp-03 treatment drug topline application trial positive phase 3
Cue Health Makes De Novo Submission to FDA for Full Clearance of Its Molecular COVID-19 Test
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
HLTH | $0.15 6.38% 6.0% 230K
|
|
| O: 0.15%
H: 8.05%
C: 4.32%
covid-19 fda clearance test health molecular submission
Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug
Published: 2022-05-02 (Crawled : 13:20) - biospace.com/
TSOI | $0.0007 0.0% 23M
|
Manufacturing
|
| O: 4.25%
H: 27.04%
C: -3.7%
covid-19 drug solutions trial international
JW MARRIOTT HOTEL SÃO PAULO MAKES ITS MINDFUL DEBUT
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 1.55%
H: 6.63%
C: 6.63%
MAR | News | $239.69 0.96% 0.91% 940K
|
Consumer Services
|
| O: 0.81%
H: 0.77%
C: -0.45%
hotel
MADE IN COOKWARE TAPS GIFTNOW TO HELP FANS SHARE THE LOVE WITH FELLOW COOKWARE CONNOISSEURS
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
SYF | $42.86 1.68% -3.17% 3.5M
|
Finance
|
| O: 0.71%
H: 0.89%
C: 0.7%
New Research Unveiled At Forrester's B2B Summit North America Urges CMOs To Redefine Marketing's Mandate
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
FORR 4 | $18.97 1.07% 1.16% 110K
|
Commercial Services
|
| O: 0.11%
H: 1.27%
C: -1.13%
america research
Blue Owl Capital Launches Owl Rock Technology Income Corporation and Breaks Escrow with $534 Million in Net Equity Proceeds
Published: 2022-05-02 (Crawled : 13:20) - prnewswire.com
OWL | $18.7 1.36% 0.53% 5.1M
|
Finance and Insurance
|
| O: 1.01%
H: 3.07%
C: 2.9%
technology blue corporation
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | $2.97 137.6% 54.87% 66M
|
Finance
VRT 4 | $79.17 4.08% 19.36% 6.6M
|
Electronic Technology
FOA 4 | $0.5144 -8.16% 15.43% 20
|
Finance and Insurance
EAST | $1.0835 16.17% 15.21% 100
|
Commercial Services
BOF | $1.17 6.36% 14.73% 15K
|
TSLA | News | $144.68 1.85% 9.01% 93M
|
Consumer Durables
BNED | $0.2064 2.64% 8.96% 1.4M
|
Retail Trade
LRN 4 | $58.2 0.17% 7.56% 950K
|
Consumer Services
TOVX | News | $0.3769 -8.3% 7.46% 1.2M
|
Manufacturing
TXN | $165.47 1.25% 6.76% 4.3M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.